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Take Home Message 33 
This paper describes a prospective clinical study showing that pre-operative categorisation of 34 
bladder outlet obstruction using non-invasive measurement of  bladder pressure by the penile 35 
cuff device can improve prediction of outcome following TURP.   36 
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Abstract 56 
Objectives: To determine whether categorisation of bladder outlet obstruction (BOO) using 57 
measurements of bladder pressure and urine flow obtained by a novel non-invasive medical 58 
device (the penile cuff test) improves prediction of outcome from endoscopic prostatectomy 59 
(TURP). 60 
 61 
Methods: A consecutive cohort of 208 men undergoing TURP following standard 62 
assessment in our institution was recruited and 179 (86%) completed the protocol. Each 63 
subject underwent a penile cuff test prior to surgery and outcome was assessed by change in 64 
IPSS at 4 months.  The proportion of men with good outcome (> 50% reduction in IPSS) was 65 
compared according to categorisation by the non-invasive bladder pressure and urine flow 66 
measurements.  67 
 68 
Results: The cuff test was completed by 93% of men with 2% experiencing an adverse 69 
event.  Men categorised as having BOO by the test (37% of total) had an 87% chance of a 70 
good outcome from TURP (p < 0.01) whilst of those deemed not obstructed (19% of total) 71 
56% experienced good outcome (p < 0.01).  For remaining men not categorised in these 2 72 
groups 77% had good outcome which was identical to the result of the cohort as a whole 73 
(77%, p > 0.05). 74 
 75 
Conclusion: Urodynamic categorisation using measurements obtained by the non-invasive 76 
penile cuff test improves prediction of outcome for men with LUTS undergoing TURP.  This 77 
finding together with the ease and acceptability of the test suggest its suitability for office-78 
based clinical use to assist men and their physicians in the selection for surgical treatment for 79 
relief of LUTS. 80 
 5 
1. Introduction 81 
Treatment options for men with lower urinary tract symptoms (LUTS) due to benign prostatic 82 
enlargement have increased over the last 20 years although surgical removal of tissue 83 
typically by transurethral resection (TURP) remains most effective [1].  This choice has 84 
focused the need for more precise diagnostic tests that can predict outcome and hence guide 85 
treatment selection [2].  Men with bladder outlet obstruction (BOO) defined by invasive 86 
pressure flow studies (PFS) have success rates following TURP 15-29% higher than those 87 
without obstruction but invasive PFS are not commonly performed because of patient 88 
discomfort, infection risk and cost associated with the need for skilled staff and specialised 89 
equipment [3].  Most UK urologists therefore suggest surgery on the basis of bothersome 90 
LUTS unresponsive to drug therapy and associated with reduced urinary flow with 65 - 75% 91 
of men achieving satisfactory symptomatic benefit [4].  Non-invasive tests that improve 92 
outcome prediction for men considering surgery would represent a useful addition to pre-93 
operative assessment and several methods are being actively pursued [5]. 94 
 95 
We have developed a non-invasive bladder pressure measurement technique involving 96 
controlled inflation during voiding of a cuff placed around the penis [6].  The cuff pressure at 97 
which flow is interrupted (pcuff.int) provides a valid and reproducible estimate of isovolumetric 98 
bladder pressure (pves.isv) – a measure of detrusor contraction strength [7].  Use of the device is 99 
well tolerated [8] and produces a plot from which maximum values of pcuff.int and peak urine 100 
flow rate (Qmax.cuff) can be read.  These measurements can then be used on a pressure flow 101 
nomogram to categorise obstruction [9]. 102 
 103 
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We have now performed a prospective study to determine whether pre-operative 104 
categorisation using the non-invasive pressure-flow nomogram improved prediction of TURP 105 
outcome compared to standard assessment alone.  106 
 7 
2. Methods 107 
Local Research Ethical Committee and institutional approval together with informed written 108 
consent were obtained and the protocol conformed to STARD guidelines [10]. 109 
 110 
2.1. Subjects 111 
Sample size estimation showed that 200 men would be sufficient to demonstrate the minimum 112 
10% improvement in outcome prediction suggested by studies using invasive PFS [3].  113 
Therefore a consecutive cohort of 208 men with LUTS scheduled for TURP was recruited 114 
from a single institution during a 15-month period from December 2003 to February 2005.  115 
Prior selection for operation was independent of the study and made on the basis of 116 
bothersome LUTS and a reduced flow rate, after the exclusion of overt prostate cancer by 117 
digital rectal examination, PSA test and, if indicated, negative biopsies.  For some men these 118 
standard criteria were supplemented by further investigation, typically invasive PFS.   119 
 120 
2.2. Experimental protocol 121 
Men completed the International Prostate Symptom Score (IPSS) and underwent an office-122 
based penile cuff test prior to surgery with the IPSS repeated approximately 4 months 123 
following surgery to determine outcome.  Subjects who were able to manage a second void 124 
following the cuff test also underwent standard uroflowmetry recording maximum flow rate 125 
(Qmax) and voided volume (Vvoid).  Prior to conclusion of the study we decided to seek 126 
additional longer term outcome and patient satisfaction data by assessing patient-perceived 127 
outcome at 24 months.  Available patients were contacted by telephone and were asked to rate 128 
the result of TURP on a 10 point scale from complete failure (0) to complete success (10). 129 
The patient and operating surgeon were unaware of the pre-operative study results and 130 
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researchers performing the assessments played no part in the standard clinical management of 131 
men recruited for the study. 132 
 133 
2.3. Penile cuff test 134 
A penile cuff (Mediplus Ltd, High Wycombe, UK) was placed around the penis and the 135 
subject was asked to void without straining into a uroflowmeter connected to the cuff machine 136 
(FM319, RMPD, Freeman Hospital, Newcastle-upon-Tyne, UK) [7].  Once voiding 137 
commenced the cuff was automatically inflated at 10 cmH2O s-1 until flow was interrupted or 138 
a safety cut-off of 200 cmH2O was reached. The cuff then automatically rapidly deflated with 139 
resumption of flow allowing the process to be repeated until voiding was complete [7].  140 
Maximum values of pcuff.int and Qmax.cuff were read from the continuous plot of flow rate and 141 
cuff pressure obtained for each void (Figure 1a).  These readings were then checked by a 142 
second observer blinded to the initial result. 143 
 144 
2.4. Statistical analysis 145 
Maximum pcuff.int and Qmax.cuff recorded from the pre-operative penile cuff test were plotted on 146 
the non-invasive nomogram allowing classification of each subject as obstructed, not 147 
obstructed or diagnosis uncertain (Figure 1b) [9].  Successful symptomatic outcome was 148 
defined on the study protocol as a greater than 50% reduction in IPSS at the 4 month 149 
assessment with those achieving a lesser improvement categorised as having a poor outcome 150 
[11].  At 24 months patient-perceived success was defined as a rating of  ≥ 7 on the 10-point 151 
scale.  The number of men achieving good outcome is expressed as n {% (95% confidence 152 
interval)} using a binomial model.  The proportion of men in each of the 3 groups categorised 153 
by the penile cuff test achieving a good outcome was then compared with outcome in the 154 
group as a whole.  Likelihood ratios (LR = probability of correct result ÷ probability of 155 
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incorrect result) were used to assess prognostic accuracy whereby the higher the LR the more 156 
discriminant the test.  In order to provide a comparison using more conventional indices, this 157 
exercise was repeated with standard ‘free’ uroflowmetry data using 10 ml s-1 and 15 ml s-1 as 158 
a diagnostic cut-off values for BOO [12].  Categorical data were examined by chi-squared test 159 
for trend with significance level set at 5%.  Inter-observer variation was assessed by Bland-160 
Altman analysis. 161 
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3. Results 162 
A total of 208 men already selected for TURP using standard institutional criteria were 163 
recruited. They progressed as shown in Figure 2 with 179 (86%) completing the initial 164 
protocol and 146 (70%) responding to additional telephone follow up at a mean (SD) of 24 (5) 165 
months.  Characteristics of subjects and their operative findings were consistent with other 166 
series of men undergoing this surgery (Table 1) [4]. 167 
 168 
Of the 179 patients who completed the study 138 {77% (70-83%)} satisfied the pre-set 169 
criterion for a good symptomatic outcome at 4 months.  For the 15 (7%) men in whom we 170 
were unable to achieve a valid measurement (test failures) but who subsequently underwent 171 
TURP, 11 (73%) achieved a good outcome. A total of 15 (9%) men were unable to attend for 172 
office follow-up and completed the post-operative IPSS by telephone. Of those patients 173 
contacted at 24 months, 112 {77% (69-83%)} rated the operation as successful. 174 
 175 
Cuff inflation was well tolerated although 8 (4%) men were unable to void and 4 (2%) 176 
experienced adverse events; 3 having self-limiting urethral bleeding and 1 terminating the test 177 
due to pain.  A recording suitable for analysis could not be made in 3 (1%) subjects.  Reading 178 
of pcuff.int by a second observer showed good agreement with the initial reading with a mean 179 
(SD) difference of 0.5 (3.8) cmH2O.  Readings of the first observer were used for data 180 
analysis throughout. 181 
 182 
Excluding test failures, the non-invasive pressure-flow nomogram categorised 71 (40%) men 183 
as obstructed, 36 (20%) were not obstructed and 72 (40%) were in the areas of diagnostic 184 
uncertainty (Figure 3).  The predictive value of nomogram classification for 4-month IPSS 185 
outcome including test failures and 24-month patient rating outcome is shown in Table 2. 186 
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 187 
We obtained a separate reading for Qmax using standard uroflowmetry for 138 (77%) men.  188 
Analysis using a cut-off value of 10 ml s-1 showed that good outcome at 4 months was seen in 189 
52 of 65 men {80% (68-89%)} with Qmax ≤ 10 ml s-1 (LR for good outcome = 4.0) and in 48 190 
of 73 men {66% (54-77%)} with Qmax > 10 ml s-1 (LR for poor outcome = 0.5) compared to 191 
73% (64-79%) overall (p < 0.03, LR = 2.7 for good outcome).   Similarly if 15 ml s-1 was 192 
used as a diagnostic cut-off value 86 of 113 {76% (67-84% )} men with Qmax ≤ 15 ml s-1 had 193 
a good outcome at 4 months (LR = 3.2 for good outcome) compared to 14 of 25 {56% (35-194 
76%)}  of men with Qmax > 15 ml s-1 (LR = 0.8 for poor outcome) and 73% (64-79%) overall 195 
(p  > 0.05).196 
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4. Discussion 197 
 Population ageing and male health promotion concerning early diagnosis of prostate disease 198 
has resulted in large numbers of older men seeking medical advice concerning LUTS.  After 199 
initial exclusion of prostate cancer, it is argued that the decision to treat and the choice of 200 
treatment can be helped by differentiating between BOO and detrusor underactivity which 201 
requires measurement of bladder pressure and urine flow during voiding [13,14].  To 202 
overcome the practical disadvantages of invasive PFS a number of groups have attempted to 203 
measure bladder pressure indirectly, chiefly by interruption of flow [15].  Our technique plots 204 
an estimate of isovolumetric bladder pressure, pcuff.int, and a measurement of maximum flow 205 
rate, Qmax.cuff, on a nomogram to allow categorisation into obstructed, not obstructed or 206 
diagnosis uncertain groups [9].  The present study tested the usefulness of this approach in a 207 
clinically relevant setting and demonstrated that a 10% improvement in prediction of good 208 
outcome was achieved with few test-related adverse events.  Men whose measurements fall in 209 
the obstructed area have an 87% chance of a good outcome which is reassuring and 210 
encourages the use of ablative procedures for symptom relief.  Conversely those classified as 211 
not obstructed have a much reduced chance of benefit and might prefer to put up with their 212 
symptoms.  For the 45% of men whose obstructive category remained uncertain the chance of 213 
a good outcome was intermediate and similar to that predicted by standard assessment.  The 214 
choice for these men would be to accept the moderate risk of unsatisfactory symptom relief or 215 
undergo further testing, perhaps by invasive PFS, to clarify their urodynamic status.   216 
 217 
At first glance the 10% improvement in prediction of good outcome appears modest.  It 218 
should be noted however that the overall success rate without cuff test categorisation (77%) 219 
was at the upper end of previous audit results [4] and that the 87% success rate in men 220 
classified as obstructed was similar to that achieved by invasive PFS in previous studies (79 - 221 
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93%) [3]. It could also be argued that the risk of failure is a more pertinent criterion for these 222 
men and this was reduced by over 40%; from 23% to 13%.  Finally the difference in good 223 
outcome between the obstructed and not obstructed groups defined using non-invasive data 224 
(31%) is at the upper end of the range seen with invasive classification (15 – 29%) [3]. The 225 
high prevalence both of the condition and surgical intervention may also increase the impact 226 
of small improvements in outcome prediction.  In England, where 15 000 men undergo TURP 227 
for LUTS each year, good outcome could be predicted with greater certainty for 6000 men 228 
whereas for the 3000 men classified as not obstructed the risk - benefit ration would merit 229 
more careful consideration and a proportion might opt for continued surveillance [16].  230 
 231 
The next question is whether addition of the cuff test gave better prediction of outcome than 232 
existing tests known to define BOO, chiefly invasive PFS and ‘free’ uroflowmetry.  Direct 233 
comparison with invasive PFS was not an aim of the present study but of the 49 men who 234 
underwent both investigations a good outcome was seen for 32 of the 44 (73%) men with 235 
BOO on invasive studies compared to 17 of the 18 (94%) men categorised as obstructed using 236 
non-invasive data.  It should be noted however that for 22 (45%) of these men the non-237 
invasive diagnosis was uncertain and that any comparison is severely compromised by 238 
selection bias.  Fair comparison with ‘free’ uroflowmetry was hampered by the fact that a low 239 
flow rate was part of the standard selection criteria for TURP and by our inability to capture 240 
complete data for this purpose.  Despite these caveats the cuff test was better than flow rate 241 
alone both in terms of improvement in prediction of good outcome over standard assessment 242 
where a 7% advantage was seen and by improved separation of obstructed and not obstructed 243 
groups with a 10% advantage.  Consideration of the LR also shows that categorisation using 244 
the non-invasive nomogram (LR = 6.7) gave improved prognostic accuracy over flow rate 245 
alone (LR = 4.0).  At present we are unable to categorise 45% of men using cuff test 246 
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measurements.  This includes 15 (7%) men in whom we could not obtain an acceptable 247 
recording, a proportion similar to invasive PFS [17].  Whilst this does not affect the predictive 248 
value of plots in the obstructed and unobstructed areas it does mean that these men would 249 
require further testing to more accurately predict their likely outcome and represents a 250 
drawback that the cuff test has in common with invasive studies. 251 
 252 
The categorising of health states using cut-off values of continuous variables in the 253 
nomogram and outcome definition is a shortcoming of our study since small numerical 254 
differences may change category. We have persisted with this approach because it fits with 255 
current practice in the assessment of men with LUTS and it is reassuring that longer term 256 
outcome using a simple patient rating scale were similar overall to that seen at 4 months with 257 
IPSS.  In the future, a Bayesian approach may be more appropriate whereby the results of the 258 
cuff test would add to those of other assessments to either increase or decrease clinicians’ 259 
perception of the probability of obstruction or treatment benefit [18].  This probability-based 260 
approach may also help identify the significant number of men (10% of our sample) destined 261 
to have a good outcome from prostate ablation despite being classified as not obstructed.  It is 262 
also possible that use of alternative single or multiple criteria such as voiding symptom scores 263 
or other indices may be useful in this regard [19]. 264 
 265 
The sample of men used in the present study had already been selected for surgery in a single 266 
UK institution on the basis of severe symptoms and reduced urinary flow rate.  They therefore 267 
represent a particular sub-group of the population of men complaining of LUTS and it 268 
remains uncertain whether the encouraging results of the present study are repeatable in 269 
different centres and across different patient groups.  We currently feel that the cuff test works 270 
well as an elective extension to ‘free’ uroflowmetry since it potentially reduces the number of 271 
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men requiring PFS by over 50% and allows individual patients a more informed choice.  It 272 
could be argued however that patient benefit is confined to the 37% of men who are 273 
categorised as obstructed with the rest requiring additional investigation to establish 274 
urodynamic diagnosis.  Further studies are certainly needed to clarify these issues and 275 
establish the role of the test earlier in the assessment of men with LUTS due to BPE prior to 276 
selection for surgery.  We are currently conducting a multi-centre trial to address some of 277 
these issues.    278 
 279 
5. Conclusion 280 
For men with bothersome LUTS considering surgical options for symptom relief, this simple 281 
office- based test allows categorisation of bladder outflow obstruction using non-invasive 282 
pressure and flow measurements.  The improved prediction of outcome from TURP that 283 
results from this categorisation can aid patient and physician in their choice of treatment. 284 
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8. Tables 385 
 386 
Table 1: Characteristics of patient cohort 387 
 388 
Variable Descriptive 
Number of patients 179* 
Age mean (range) 69 (47 – 88) years 
Pre-operative IPSS (0-35) mean (SD)  22 (7) 
Pre-operative IPSS QoL (0-5) mean (SD) 4 (1) 
Pre-operative Qmax mean (SD) 10.8 (4.7) ml s-1 
Pre-operative residual volume mean (SD) 130 (123) ml 
Pre-operative invasive PFS performed (%) 49 (27) 
Resected weight mean (SD) 16.7 (12) g 
Men with prostate cancer in resected prostate (%) 19 (11%) 
Surgical success rate % 77% 
 389 
*Excludes 15 subjects for whom cuff test measurements were not obtained  390 
 391 
 392 
 393 
 394 
 395 
 396 
 397 
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Table 2: Surgical outcome for all subjects overall and following classification into 398 
obstructed, uncertain and not obstructed groups according to the nomogram. Outcomes were 399 
measured by IPSS questionnaire at 4 months, and separately by telephone interview at 24 400 
months.  Numbers (n) of subjects in each group achieving a good outcome compared to the 401 
total together with percentage good outcome (95% confidence intervals) are given.  To assess 402 
prognostic accuracy likelihood ratios (LR) are given where LR = probability correct result ÷ 403 
probability of incorrect result (LR 5 – 10 = moderate change, LR = 2 – 5 small change).   404 
 405 
Pre-operative cuff test nomogram classification 
 All subjects 
Obstructed Uncertain Not obstructed 
Good outcome 
(IPSS @ 4 months) 
n = 149 of 194* 
77% (70-83%) 
LR = 3.3 
 
n = 62 of 71 
87% (77-93%) 
LR = 6.7 
p < 0.01 
n = 67 of 87* 
77% (67-85%) 
LR = 3.3 
N.S. 
n = 20 of 36 
56% (40-71%) 
LR =  0.8 
p < 0.01 
Good outcome 
(Patient rating @ 24 
months) 
n = 112 of 146 
77% (69-83%) 
LR = 3.3 
 
n = 53 of 60 
88% (78-95%) 
LR= 7.3 
p < 0.01 
n = 45 of 57 
79% (66-89%) 
LR = 3.8 
N.S. 
n = 14 of 29 
48% (30-68%) 
LR = 1.1 
p < 0.01 
 406 
* For those assessed at 4 months the total number of subjects and the number of men 407 
categorised as diagnosis uncertain includes 15 men in whom we failed to get valid cuff 408 
measurements but who subsequently underwent TURP 409 
 410 
 411 
 412 
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Figure 1a: Pressure flow recording from the penile cuff test for a single void showing 413 
reading of maximum pcuff.int (168 cmH20) and Qmax.cuff (8.9 ml s-1) for a voided 414 
volume of 317 ml. 415 
 416 
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 417 
 418 
 419 
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Figure 1b:  Plotting of the measured readings for the subject’s pressure flow plot (Figure 420 
1a) for maximum pcuff.int and Qmax.cuff on the non-invasive nomogram 421 
categorises the subject as obstructed. 422 
 423 
 424 
 425 
 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
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Figure 2: Patient flow chart for study 435 
 436 
 437 
Figure 3: Pre-operative nomogram position. The nomogram is divided into diagnostic 438 
quadrants according to flow and pressure cut-off lines. The points are labelled 439 
according to subsequent symptomatic outcome as determined by change in 440 
IPSS at 4 months. 441 
 442 
